Noteworthy Tuesday Option Activity: TDOC, AEHR, ELF

Aehr Test Systems (AEHR) saw 2,661 options contracts trade today (≈266,100 underlying shares), representing ~49.2% of its one‑month average daily volume of 540,490 shares; the most active was the $22.50 call expiring Feb 20, 2026 (649 contracts, ≈64,900 shares). e.l.f. Beauty (ELF) had 7,892 contracts trade (≈789,200 underlying shares), about 48.4% of its one‑month ADTV of 1.6M shares, led by the $81 call expiring Jan 9, 2026 (952 contracts, ≈95,200 shares). The outsized call volumes relative to ADTV indicate concentrated short‑term positioning that could amplify near‑term price moves and liquidity impacts in both stocks.

Analysis

Market structure: Concentrated long-dated call flow in AEHR (649 contracts at $22.50 Feb-20-2026 ≈64.9k shares) and ELF (952 contracts at $81 Jan-09-2026 ≈95.2k shares) creates short-term net buy pressure via dealer delta-hedging equivalent to an estimated ~32k AEHR shares (~6% of AEHR ADV assuming 0.5 delta) and ~48k ELF shares (~3% of ELF ADV). Direct beneficiaries are directional call buyers and liquidity providers who collect premium; hurt are naked short sellers and illiquid passive holders who may face transient slippage. The signal is tactical demand for upside optionality rather than durable supply tightening — fundamentals still govern medium-term share direction.

Risk assessment: Immediate (days) risk is washout or squeeze from dealer hedging; short-term (weeks–months) risk is volatility collapse if flows are reversed or if flows are part of structured/hedged positions (synthetics) that unwind. Tail risks include adverse earnings/guide-downs, supply-chain shocks for AEHR, or holiday sales misses for ELF that could flip IV and trigger 30–60% moves; regulatory risk is low but liquidity/operational risk in small-cap AEHR is material. Hidden dependency: large blocks could be matched trades (call purchase funded by sell of further-dated calls) — monitor changes in calendar spread skew and IV term structure.

Trade implications: For AEHR, the flow supports a tactical bullish options exposure but size to idiosyncratic risk — prefer a Feb-2026 $22.50–$27.50 call debit spread to limit cost, target 2–3x return if AEHR >$27 by Feb, stop if price < $18 or IV falls >30% from entry. For ELF, consider an earnings/holiday diagonal (buy Jan-2026 $81 call, sell nearer-term $75–$85 calls) or a 2% equity long with covered-call overlay into Jan-2026 to collect premium; avoid naked long gamma without defined loss. Also consider a relative-value pair: long AEHR (1% NAV) vs short SMH (0.25% NAV) to isolate idiosyncratic upside while capping sector beta.

Contrarian angles: The market may be misreading high call volume as pure bullish conviction — flows could be vola buyers hedging larger equity short positions or part of structured-note hedges, meaning upside may fail to materialize. Overdone risk: AEHR’s small-cap liquidity means a few blocks push price temporarily; if open interest/flow does not persist for 2+ weeks, mean reversion likely. Use objective triggers (AEHR < $18, ELF miss relative holiday comps >5%) to invalidate bullish stance and flip to protective puts or unwind spreads.

Key Decisions for Investors

• AEHR: Establish a capped-exposure bullish spread — buy Feb-2026 $22.50 / sell $27.50 call debit spread sized to ~1–1.5% NAV (e.g., 3–6 contracts per $1M AUM). Target: close on 2.0–3.0x premium or if AEHR > $27 by expiry; stop-loss: close if AEHR < $18 or IV drops >30% from entry.
• ELF: Build a 1.5–2.0% NAV directional position via a diagonal/covered-call approach: buy Jan-2026 $81 calls (or 1% equity) and sell nearer-term $75–$85 calls to finance cost. Close or roll if holiday sales metrics (weekly Nielsen/IRI or company-reported comps) underperform consensus by >5% within 60 days.
• Pair trade: Long AEHR (0.8–1.0% NAV equity) vs short SMH (0.2–0.3% NAV) to capture idiosyncratic upside while limiting semiconductor-sector beta; rebalance weekly and unwind if relative performance crosses ±8% vs entry after 30 days.